4 Results for "

BTK-IN-14

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BTK-IN-14" in MCE Product Catalog:

Cat. No.: HY-147584
CAS No.: 2764674-60-2
Target:  

Btk

Research Areas:  

Inflammation/Immunology Cancer

BTK-IN-14 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-14 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022057894A1, compound 1) .
loading...
    loading...
Cat. No.: HY-173126
Research Areas:  

Others

BTK ligand-14 is a PROTAC target protein ligand that targets BTK and can be used for the synthesis of FDU73 (HY-173125) .
loading...
    loading...
Cat. No.: HY-181623
CAS No.: 3114684-06-6
Target:  

PROTACs Btk

Research Areas:  

Cancer

PROTAC BTK degrader-14 (compound 112) is a PROTAC protein degrader targeting BTK. PROTAC BTK degrader-14 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-181624
Research Areas:  

Cancer

BTK ligand-19 is a PROTAC ligand of BTK, which is used to synthesize the PROTAC-based BTK degrader PROTAC BTK degrader-14 (HY-181623). BTK ligand-19 regulates cell apoptosis, cell cycle progression and kinase signaling cascades. BTK ligand-19 is applied in cancer research .
loading...
    loading...